Stephen P. Squinto

Biography

 In January 2015 Dr. Squinto became a venture partner with OrbiMed Advisors, the world’s largest venture capital firm focused on healthcare. Prior to January 2015, Dr. Squinto was a co-founder of Alexion Pharmaceuticals, Inc. (www.alxn.com) and had been a Corporate Officer since August 2000. Most recently, Dr. Squinto was the Executive Vice President and Chief Global Operations Officer, a member of the Executive Steering Committee and was responsible for Global Manufacturing, Quality and Project Management. Prior to 2013 he was the Global Head of Research and Development, a position he has held since 2007 where he was responsible for Clinical Development, Medical Affairs, Regulatory Affairs, Pharmacovigilence, Drug Discovery, Translational Medicine and Portfolio Management. Other positions he has held at Alexion include, Executive VP, Head of Research and Clinical Development from 2006-2007, Executive VP, Head of Research from 2000-2006, Senior Vice President and Chief Technology Officer from 1998 to 2000, Vice President of Research, Molecular Sciences, from 1994 to 1998, Senior Director of Molecular Sciences from 1993 to 1994 and Director of Molecular Development from 1992 to 1993. Prior to 1992, Dr. Squinto held various positions at Regeneron Pharmaceuticals, Inc., including serving as the Co-Director of the Drug Discovery Group. Dr. Squinto was among the founding scientists hired at Regeneron in 1989. Prior to his position at Regeneron, Dr. Squinto held a joint appointment as an Assistant Professor of Biochemistry and Molecular Biology and Neuroscience at both Tulane University Medical School and Louisiana State University Medical Center from 1986 to 1989. Dr. Squinto is a recipient of numerous honors and awards from academic and professional organizations and his scientific work has led to over 70 scientific publications and over 40 patents in the fields of molecular biology, biochemistry, biotechnology and neuroscience. He currently serves on the boards of several private companies as well as several charitable organizations. Dr. Squinto received his B.A. in Chemistry and Ph.D. in Biochemistry and Biophysics from Loyola University of Chicago.

Research Interest

 Molecular science, Business Management